Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 51.80K |
Day Range | - - - |
52 Wk Range | 1.57 - 4.48 |
Market Cap | $27.73M |
P/E Ratio | 1.10 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 0.32% |
Days to Cover | 2.44 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of VYNE Therapeutics (NASDAQ:VYNE) through any online brokerage.
Other companies in VYNE Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX) and CalciMedica (NASDAQ:CALC).
VYNE Therapeutics has a consensus price target of $7.38.
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $1.88 last updated September 13, 2024 at 7:12 PM EDT.
There are no upcoming dividends for VYNE Therapeutics.
VYNE Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for VYNE Therapeutics.
VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.